chr22-43159399-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_000714.6(TSPO):c.161G>A(p.Gly54Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00000848 in 1,533,392 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000714.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000743 AC: 1AN: 134520 AF XY: 0.0000139 show subpopulations
GnomAD4 exome AF: 0.00000724 AC: 10AN: 1381208Hom.: 0 Cov.: 32 AF XY: 0.00000881 AC XY: 6AN XY: 680936 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74344 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.161G>A (p.G54D) alteration is located in exon 2 (coding exon 1) of the TSPO gene. This alteration results from a G to A substitution at nucleotide position 161, causing the glycine (G) at amino acid position 54 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at